Cargando…
Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program
BACKGROUND: In Côte d'Ivoire during 2004–2007, numbers of ART enrollees increased from <5,000 to 36,943. Trends in nationally representative ART program outcomes have not yet been reported. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a retrospective chart review to assess trends in patient...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035349/ https://www.ncbi.nlm.nih.gov/pubmed/24866468 http://dx.doi.org/10.1371/journal.pone.0098183 |
_version_ | 1782318052159782912 |
---|---|
author | Auld, Andrew F. Ekra, Kunomboa A. Shiraishi, Ray W. Tuho, Moise Z. Kouakou, Joseph S. Mohamed, Fayama Ettiègne-Traoré, Virginie Sabatier, Jennifer Essombo, Joseph Adjorlolo-Johnson, Georgette Marlink, Richard Ellerbrock, Tedd V. |
author_facet | Auld, Andrew F. Ekra, Kunomboa A. Shiraishi, Ray W. Tuho, Moise Z. Kouakou, Joseph S. Mohamed, Fayama Ettiègne-Traoré, Virginie Sabatier, Jennifer Essombo, Joseph Adjorlolo-Johnson, Georgette Marlink, Richard Ellerbrock, Tedd V. |
author_sort | Auld, Andrew F. |
collection | PubMed |
description | BACKGROUND: In Côte d'Ivoire during 2004–2007, numbers of ART enrollees increased from <5,000 to 36,943. Trends in nationally representative ART program outcomes have not yet been reported. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a retrospective chart review to assess trends in patient characteristics and attrition [death or loss to follow-up (LTFU)] over time, among a nationally representative sample of 3,682 adults (≥15 years) initiating ART during 2004–2007 at 34 health facilities. Among ART enrollees during 2004–2007, median age was 36, the proportion female was 67%, the proportion HIV-2-infected or dually HIV-1&2 reactive was 5%, and median baseline CD4(+) T-cell (CD4) count was 135 cells/µL. Comparing cohorts initiating ART in 2004 with cohorts initiating ART in 2007, median baseline weight declined from 55 kg to 52 kg (p = 0.008) and the proportion weighing <45 kg increased from 17% to 22% (p = 0.014). During 2004–2007, pharmacy-based estimates of the percentage of new ART enrollees ≥95% adherent to ART declined from 74% to 60% (p = 0.026), and twelve-month retention declined from 86% to 69%, due to increases in 12-month mortality from 2%–4% and LTFU from 12%–28%. In univariate analysis, year of ART initiation was associated with increasing rates of both LTFU and mortality. Controlling for baseline CD4, weight, adherence, and other risk factors, year of ART initiation was still strongly associated with LTFU but not mortality. In multivariate analysis, weight <45 kg and adherence <95% remained strong predictors of LTFU and mortality. CONCLUSIONS: During 2004–2007, increasing prevalence among ART enrollees of measured mortality risk factors, including weight <45 kg and ART adherence <95%, might explain increases in mortality over time. However, the association between later calendar year and increasing LTFU is not explained by risk factors evaluated in this analysis. Undocumented transfers, political instability, and patient dissatisfaction with crowded facilities might explain increasing LTFU. |
format | Online Article Text |
id | pubmed-4035349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40353492014-06-02 Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program Auld, Andrew F. Ekra, Kunomboa A. Shiraishi, Ray W. Tuho, Moise Z. Kouakou, Joseph S. Mohamed, Fayama Ettiègne-Traoré, Virginie Sabatier, Jennifer Essombo, Joseph Adjorlolo-Johnson, Georgette Marlink, Richard Ellerbrock, Tedd V. PLoS One Research Article BACKGROUND: In Côte d'Ivoire during 2004–2007, numbers of ART enrollees increased from <5,000 to 36,943. Trends in nationally representative ART program outcomes have not yet been reported. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a retrospective chart review to assess trends in patient characteristics and attrition [death or loss to follow-up (LTFU)] over time, among a nationally representative sample of 3,682 adults (≥15 years) initiating ART during 2004–2007 at 34 health facilities. Among ART enrollees during 2004–2007, median age was 36, the proportion female was 67%, the proportion HIV-2-infected or dually HIV-1&2 reactive was 5%, and median baseline CD4(+) T-cell (CD4) count was 135 cells/µL. Comparing cohorts initiating ART in 2004 with cohorts initiating ART in 2007, median baseline weight declined from 55 kg to 52 kg (p = 0.008) and the proportion weighing <45 kg increased from 17% to 22% (p = 0.014). During 2004–2007, pharmacy-based estimates of the percentage of new ART enrollees ≥95% adherent to ART declined from 74% to 60% (p = 0.026), and twelve-month retention declined from 86% to 69%, due to increases in 12-month mortality from 2%–4% and LTFU from 12%–28%. In univariate analysis, year of ART initiation was associated with increasing rates of both LTFU and mortality. Controlling for baseline CD4, weight, adherence, and other risk factors, year of ART initiation was still strongly associated with LTFU but not mortality. In multivariate analysis, weight <45 kg and adherence <95% remained strong predictors of LTFU and mortality. CONCLUSIONS: During 2004–2007, increasing prevalence among ART enrollees of measured mortality risk factors, including weight <45 kg and ART adherence <95%, might explain increases in mortality over time. However, the association between later calendar year and increasing LTFU is not explained by risk factors evaluated in this analysis. Undocumented transfers, political instability, and patient dissatisfaction with crowded facilities might explain increasing LTFU. Public Library of Science 2014-05-27 /pmc/articles/PMC4035349/ /pubmed/24866468 http://dx.doi.org/10.1371/journal.pone.0098183 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Auld, Andrew F. Ekra, Kunomboa A. Shiraishi, Ray W. Tuho, Moise Z. Kouakou, Joseph S. Mohamed, Fayama Ettiègne-Traoré, Virginie Sabatier, Jennifer Essombo, Joseph Adjorlolo-Johnson, Georgette Marlink, Richard Ellerbrock, Tedd V. Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program |
title | Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program |
title_full | Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program |
title_fullStr | Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program |
title_full_unstemmed | Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program |
title_short | Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Côte d'Ivoire's National Antiretroviral Therapy Program |
title_sort | temporal trends in treatment outcomes for hiv-1 and hiv-2-infected adults enrolled in côte d'ivoire's national antiretroviral therapy program |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035349/ https://www.ncbi.nlm.nih.gov/pubmed/24866468 http://dx.doi.org/10.1371/journal.pone.0098183 |
work_keys_str_mv | AT auldandrewf temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT ekrakunomboaa temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT shiraishirayw temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT tuhomoisez temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT kouakoujosephs temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT mohamedfayama temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT ettiegnetraorevirginie temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT sabatierjennifer temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT essombojoseph temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT adjorlolojohnsongeorgette temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT marlinkrichard temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram AT ellerbrockteddv temporaltrendsintreatmentoutcomesforhiv1andhiv2infectedadultsenrolledincotedivoiresnationalantiretroviraltherapyprogram |